MIR22HG and breast carcinoma: Furthermore, the colony formation assay and Transwell assay results of breast cancer cells co-transfected with miR-629-5p and wild-type/mutant MIR22HG revealed that only the wild-type MIR22HG impaired the function of miR-629-5p in breast cancer cells (Fig. 5a, b).